A decade after the discovery of CALR, the results are the first for a possible therapy for CALR-mutated MPNs to reach the ...

PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and ...

Neutrophil-to-lymphocyte ratio (NLR) is a significant prognostic indicator in myeloproliferative neoplasms, correlating with ...

A high platelet count refers to the small cells that help blood clot. Also called thrombocytosis or thrombocythemia, a high platelet count is more than 450,000 platelets per microliter of blood. A ...

Get detailed information on Anagrelide, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

This is called primary thrombocythemia. If it's caused by an underlying disorder that triggers the stem cells in your bone marrow to make more platelets, it's called secondary thrombocytosis.

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, ...

Patients aged 18 years or older with primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia myelofibrosis who did not achieve a response on or relapsed ...

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and ...